Selcia and Gilead Sciences have entered into a drug discovery partnership that will focus on medicines to treat liver diseases.
Building on an established partnership, Selcia will provide its integrated drug discovery services to support Gilead’s liver disease research programmes.
Go deeper with GlobalData
The collaboration will focus on delivering candidates for clinical studies.
Selcia managing director Dr Hans Fliri said that the company was looking forward to support Gilead in the search for new drugs to treat liver diseases.
How well do you really know your competitors?
Access the most comprehensive Company Profiles on the market, powered by GlobalData. Save hours of research. Gain competitive edge.
Thank you!
Your download email will arrive shortly
Not ready to buy yet? Download a free sample
We are confident about the unique quality of our Company Profiles. However, we want you to make the most beneficial decision for your business, so we offer a free sample that you can download by submitting the below form
By GlobalData
